Fuertes, Thelma C.
HRN: 22-58-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/12/2025
05/26/2025
IV
4.5
Q8
Sacral Ulcer, Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes